Spyre Therapeutics (SYRE) Net Margin (QoQ) (2015 - 2023)
Powered by 
Analysis
Spyre Therapeutics (SYRE) Net Margin (QoQ) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 10 | Spyre Therapeutics | 7.50 Bn | 7.50 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -2.22 Mn |
| Mar 31, 2023 | 189,953.00 |
| Dec 31, 2022 | -72,426.00 |
| Sep 30, 2022 | -690,763.00 |
| Jun 30, 2022 | -177,755.00 |
| Mar 31, 2022 | -123,304.00 |
| Dec 31, 2021 | -39,186.00 |
| Sep 30, 2021 | -11,936.00 |
| Jun 30, 2018 | 14,088.00 |
| Mar 31, 2018 | -10,901.00 |
| Dec 31, 2017 | 18,672.00 |
| Sep 30, 2017 | -17,587.00 |
| Jun 30, 2017 | 18,743.00 |
| Mar 31, 2017 | -19,534.00 |
| Dec 31, 2016 | 10,321.00 |
| Sep 30, 2016 | -14,742.00 |
| Jun 30, 2016 | 13,385.00 |
| Mar 31, 2016 | -27,779.00 |
| Dec 31, 2015 | 6,653.00 |
| Sep 30, 2015 | -27,644.00 |